Detailed Characterization of Brain Dysfunction in a Long-Term Rodent Model of Critical Illness
| Autor: | Josiane Budni, Diogo Dominguini, Milena Carvalho Silva, Francielle Mina, Mariane Abatti, Renata C. Gonçalves, Emilio L. Streck, Andressa Manfredini, Celso Carneiro Carvalho, Felipe Dal-Pizzol, Monique Michels, Amanda V. Steckert |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Elevated plus maze Critical Illness Central nervous system Hippocampus Rodentia Biochemistry Cellular and Molecular Neuroscience chemistry.chemical_compound Neurochemical Cortex (anatomy) Internal medicine Intensive care medicine Animals Cognitive Dysfunction Rats Wistar Neuroinflammation business.industry Zymosan Brain General Medicine Rats Disease Models Animal Oxidative Stress medicine.anatomical_structure Endocrinology chemistry business |
| Zdroj: | Neurochemical Research. 47:613-621 |
| ISSN: | 1573-6903 0364-3190 |
| Popis: | Critical illness encompasses a wide spectrum of life-threatening clinical conditions requiring intensive care. Our objective was to evaluate cognitive, inflammatory and cellular metabolism alterations in the central nervous system in an animal model of critical illness induced by zymosan. For this Wistar rats that were divided into Sham and zymosan. Zymozan was administered once intraperitoneally (30 g/100 g body weight) diluted in mineral oil. The animals were submitted to behavioral tests of octagonal maze, inhibitory avoidance and elevated plus maze. Brain structures (cortex, prefrontal and hippocampus) were removed at 24 h, 4, 7 and 15 days after zymosan administration for analysis of cytokine levels (TNF-α, IL-1b, IL-6 and IL-10), oxidative damage and oxygen consumption. Zymosan-treated animals presented mild cognitive impairment both in aversive (inhibitory avoidance) and non-aversive (octagonal maze) tasks by day 15. However, they did not show increase in anxiety (elevated-plus maze). The first neurochemical alteration found was an increase in brain pro-inflammatory cytokines (IL-1β, IL-6 and TNF-α) at day 4th in the hippocampus. In cortex, a late (7 and 15 days) increase in TNF-α was also noted, while the anti-inflammatory cytokine IL-10 decrease from 4 to 15 days. Oxygen consumption was decreased in the hippocampus and pre-frontal, but not cortex, only at 7 days. Additionally, it was observed a late (15 days) increase in oxidative damage parameters. This characterization of brain dysfunction in rodent model of critical illness reproduces some of the alterations reported in humans such neuropsychiatric disorders, especially depression, memory loss and cognitive changes and can add to the nowadays used models. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink